Genomic test co-invented by UBC researchers can help millions of breast cancer patients safely avoid chemotherapy

Millions of people with breast cancer could safely avoid chemotherapy thanks to a genomic test co-invented and co-developed by UBC faculty of medicine professor Dr. Torsten Nielsen, according to results from a major international clinical trial involving more than 4,400 patients with high-risk breast cancer. Developed through two decades of research led by Dr. Nielsen and collaborators, the…